Next Article in Journal
Analysis of the Effect of Various Potential Antimicrobial Agents on the Quality of the Unpasteurized Carrot Juice
Previous Article in Journal
Development of Iron–Silicate Composites by Waste Glass and Iron or Steel Powders
 
 
Article
Peer-Review Record

Rutaecarpine Ameliorates Murine N-Methyl-N’-Nitro-N-Nitrosoguanidine-Induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway

Molecules 2023, 28(17), 6294; https://doi.org/10.3390/molecules28176294
by Yong He 1, Hong-Hong Liu 2, Xue-Lin Zhou 3, Ting-Ting He 2, Ao-Zhe Zhang 2, Xin Wang 1, Shi-Zhang Wei 2, Hao-Tian Li 2, Li-Sheng Chen 1, Lei Chang 4, Yan-Ling Zhao 1,2,* and Man-Yi Jing 2,*
Reviewer 1: Anonymous
Reviewer 2:
Molecules 2023, 28(17), 6294; https://doi.org/10.3390/molecules28176294
Submission received: 14 May 2023 / Revised: 25 July 2023 / Accepted: 18 August 2023 / Published: 28 August 2023

Round 1

Reviewer 1 Report

He et. al showed a that Rutaecarpine can improve CAG, similar to what they have previously shown where RUT exerted a gastroprotective effect against gastric mucosal injury induced by ethanol. The underlying mechanism might be associated with the improvement of anti-inflammatory and anti-apoptosis mechanism. The current manuscript shows for the first time that RUT somehow improves CAG but restoring the SHH signalling and activating anti-apoptosis mechanism. However, the histological pictures presented were not so convincing. Is there a dose dependent effect of RUT in vivo? It was also not clear whether RUT+ SHH antagonist showed the same phenotype as the model. It would be good if the authors quantify the histological score of each rat.

It will also help to strengthen the conclusion of the manuscript by adding Vismodegib +MNNG control group in the in vitro experiments.

Patched1 inhibition is an important readout to indicate the activation of HH signalling. It would help if the authors also include this.

The language use is fine but requires minor editing.

Author Response

Dear editor,

It is a great honor for us to revise the manuscript entitled “Rutaecarpine Ameliorates Murine MNNG-induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway

” (Manuscript NO: molecules-2423288). We have carefully revised the manuscript and resubmitted it to Molecules online in with your kind suggestions. The response letter had contained a point-by-point reply to the peer comments. Please see the revised manuscript. Thank you so much for your time and your work on this manuscript. The main corrections in the paper and response to the reviewer’s comments are as follows:

Comments from the reviewers:

-Reviewer 1

We are truly grateful for your time and effort in thoroughly reviewing and evaluating the manuscript, as your constructive feedback has been instrumental in shaping the final edition of this paper. Our response to your question is as follows:

*1. the histological pictures presented were not so convincing

Reply: We took this recommendation seriously and reconstructed the pathology correlates. The new image shows the damage of gastric tissue more clearly, and I hope it will be recognized by the reviewers.

*2 Is there a dose dependent effect of RUT in vivo?

Reply:The doses of RUT20mg/kg/d and 10mg/kg/d in vivo experiments were observed only, so we did not investigate the dose-dependent issue. If there will be a follow-up study, we will pay more attention to the dose-dependent design.

 

*3 Patched1 inhibition is an important readout to indicate the activation of HH signalling. It would help if the authors also include this.

 

Reply: Indeed, we were originally designed to detect the WB validation of the patch1 protein. The positive rate was not good enough due to the molecular weight of this protein was 124-128 kDa and lack of the quality of the specific antibody. In order to ensure the objectivity and authenticity of the results, we abandoned it. However, the lack of patch1 protein does not affect our analysis of the results of SHH pathway due to the other important proteins results are positive.

 

Reviewer 2 Report

The manuscript needs minor revision. Please see comments given in the text of reviewed attached file of the manuscript.

Comments for author File: Comments.pdf

Author Response

Dear editor,

It is a great honor for us to revise the manuscript entitled “Rutaecarpine Ameliorates Murine MNNG-induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway

” (Manuscript NO: molecules-2423288). We have carefully revised the manuscript and resubmitted it to Molecules online in with your kind suggestions. The response letter had contained a point-by-point reply to the peer comments. Please see the revised manuscript. Thank you so much for your time and your work on this manuscript. The main corrections in the paper and response to the reviewer’s comments are as follows:

Comments from the reviewers:

-Reviewer 2

We are truly grateful for your time and effort in thoroughly reviewing and evaluating the manuscript, as your constructive feedback has been instrumental in shaping the final edition of this paper. Our response to your question is as follows:

*1. The manuscript needs minor revision. Please see comments given in the text of reviewed attached file of the manuscript.

 

Reply: Thanks very much for the opinions and suggestions of the reviewers, we will re-polish the manuscript to avoid any typographical and grammatical errors.

Reviewer 3 Report

 

The research title “Rutaecarpine Ameliorates Murine MNNG-induced Chronic 2 Atrophic Gastritis by Sonic Hedgehog Pathway”

 

1.     Appropriately titled and well written the whole manuscript

2.     N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) administration combined with an irregular diet to successfully establish a CAG rat model.

3.     RUT treatment showed positive effects on CAG rats by improving the histological damage of gastric tissue and causing changes in serological indicators.

4.     In in vitro experiments, RUT increased the proliferation of GES-1 cells and ameliorated the damage induced by MNNG.

5.     The protective effect of RUT on gastric mucosal damage and GES-1 cells was associated with the upregulation of the Sonic Hedgehog (SHH) signaling pathway.

6.     RUT treatment resulted in the upregulation of anti-apoptotic proteins (Bcl-2) and downregulation of pro-apoptotic proteins (Bax and Caspase 3), indicating its potential in improving gastric cellular survival.

7.     The study provides robust and reproducible laboratory-based evidence supporting RUT as a potential treatment for chronic atrophic gastritis.

After Line number 81, need to cite the following reference:

1.     Subramaniyan V, Fuloria S, Gupta G, Kumar DH, Sekar M, Sathasivam KV, Sudhakar K, Alharbi KS, Al-Malki WH, Afzal O, Kazmi I, Al-Abbasi FA, Altamimi ASA, Fuloria NK. A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer. Chem Biol Interact. 2022; 351:109735.

After Line number 386, need to cite the following reference:

2.     Fuloria S, Subramaniyan V, Karupiah S, Kumari U, Sathasivam K, Meenakshi DU, Wu YS, Guad RM, Udupa K, Fuloria NK. A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases. Antioxidants (Basel). 2020;9(11):1075.

These findings suggest that Rutaecarpine (RUT) has therapeutic potential for the treatment of chronic atrophic gastritis by improving gastric tissue damage, promoting cell survival, and modulating key signaling pathways.

Report:

After revising the suggested comments, this can be published in the journal of molecules.

 

Comments for author File: Comments.pdf

Author Response

Dear editor,

It is a great honor for us to revise the manuscript entitled “Rutaecarpine Ameliorates Murine MNNG-induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway

” (Manuscript NO: molecules-2423288). We have carefully revised the manuscript and resubmitted it to Molecules online in with your kind suggestions. The response letter had contained a point-by-point reply to the peer comments. Please see the revised manuscript. Thank you so much for your time and your work on this manuscript. The main corrections in the paper and response to the reviewer’s comments are as follows:

Comments from the reviewers:

-Reviewer 2

We are truly grateful for your time and effort in thoroughly reviewing and evaluating the manuscript, as your constructive feedback has been instrumental in shaping the final edition of this paper. Our response to your question is as follows:

*1. After Line number 81, need to cite the following reference:

  1. Subramaniyan V, Fuloria S, Gupta G, Kumar DH, Sekar M, Sathasivam KV, Sudhakar K, Alharbi KS, Al-Malki WH, Afzal O, Kazmi I, Al-Abbasi FA, Altamimi ASA, Fuloria NK. A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer. Chem Biol Interact. 2022; 351:109735. 

After Line number 386, need to cite the following reference:

  1. Fuloria S, Subramaniyan V, Karupiah S, Kumari U, Sathasivam K, Meenakshi DU, Wu YS, Guad RM, Udupa K, Fuloria NK. A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases. Antioxidants (Basel). 2020;9(11):1075.

These findings suggest that Rutaecarpine (RUT) has therapeutic potential for the treatment of chronic atrophic gastritis by improving gastric tissue damage, promoting cell survival, and modulating key signaling pathways.

 

Reply: Thank you very much for the comments and suggestions of the reviewers. We have added the above two references to the corresponding positions.

Round 2

Reviewer 2 Report

The manuscript can be accepted for publication.

Back to TopTop